Skip to main content
. Author manuscript; available in PMC: 2024 Jul 27.
Published in final edited form as: Eur Respir J. 2023 Jul 27;62(1):2300190. doi: 10.1183/13993003.00190-2023

FIGURE 3.

FIGURE 3

a) Interaction between baseline REVEAL 2.0 risk by treatment on change in 6-min walk distance (6MWD). b) Pre- and post-treatment 6MWD stratified by baseline REVEAL 2.0 risk. REVEAL 2.0: US Registry to Evaluate Early and Long-Term PAH Disease Management.